目前美国FDA批准的治疗AD的临床药物以调节神经递质为主，虽然能缓解症状，但疗效有限，难以逆转疾病进展。
Current FDA-approved drugs for AD aim at the correction of neurotransmitter abnormalities. They produce limited symptomatic effects but do not slow disease progression.
它增加了代谢效率，调节了神经递质和大脑氧含量，大脑使用了身体20%的氧气。
It increases metabolism efficiency, regulates neurotransmitters, and boosts oxygen levels in the brain which USES 20% of the body's oxygen.
查德勒说：“不同神经递质之间的平衡帮助调节人的情绪。”
"It is the balance between different neurotransmitters that helps regulate mood," Chudler says.
应用推荐